Cunfang Wang

Title: **Cunfang Wang: Innovator in Pharmaceutical Crystallization**

Introduction

Cunfang Wang, based in Guangdong, China, is an accomplished inventor whose work focuses on pharmaceutical innovations. He is recognized for his significant contribution to the field with a patent that enhances drug formulation stability and efficiency.

Latest Patents

Cunfang Wang holds a patent for the "Crystalline form I of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside." This invention relates to a novel crystalline form of the compound known as polydatin. The crystalline form I exhibits a stable morphology, a defined melting point, and improved chemical stability. These characteristics are pivotal for the preparation of solid formulations, allowing for reduced raw material costs, streamlined production processes, and enhanced quality control in industrial drug manufacturing. Additionally, it provides better convenience for storage.

Career Highlights

Wang’s work at Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd. has positioned him as a key player in the realm of pharmaceutical research and development. His innovative approach to compound crystallization has created new avenues for drug formulation strategies, significantly impacting the efficiency and feasibility of production.

Collaborations

Throughout his career, Cunfang Wang has collaborated with notable colleagues such as Hui Kang and Jinhua Zhao. These partnerships have fostered a creative and productive environment, contributing to the advancement of pharmacological sciences and the enhancement of drug formulation techniques.

Conclusion

Cunfang Wang's patent for the crystalline form of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside stands as a testament to his innovative spirit in the pharmaceutical industry. His contributions, alongside his esteemed colleagues, continue to shape the future of drug development, offering improved solutions for pharmaceutical challenges.